Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New York · 2025 Regular Session · Bill

A 9360: Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for certain purposes

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

A 9360 is a bill introduced in the New York House on December 19, 2025. According to its official title, it concerns: Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for certain purposes. Primary sponsor: Angelo Santabarbara (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for obesity, metabolic disorders, and autism-related compulsive eating behaviors.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Angelo SantabarbaraPrimary sponsorDemocraticHouse111

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. REFERRED TO HEALTH
  2. REFERRED TO HEALTH

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source